Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
Allarity Therapeutics Inc (NASDAQ:ALLR) shares are trading lower by 28.40% to $0.32 during Monday's session after the company announced it received a noncompliance letter from the Nasdaq.
Allarity Therapeutics Inc（纳斯达克代码：ALLR）股票在周一交易中下跌28.40%，至0.32美元/股，此前公司宣布收到了来自纳斯达克的一封“不合规函”。来自纳斯达克的不合规函。来自纳斯达克。
On June 18, Allarity received a notice from Nasdaq indicating the company failed to meet the requirement of maintaining a minimum bid price of $1 per share for 30 consecutive business days. Allarity plans to request a hearing to appeal for continued listing.
6月18日，Allarity收到了纳斯达克的通知，指出公司未能维持每股1美元的最低买盘价格连续30个工作日。Allarity计划请求听证会，申诉继续上市。此申请将暂时阻止其股票被暂停和退市，直至听证会结束。然而，不保证上诉会成功，公司的股票将继续在纳斯达克创业板上市。
This request will temporarily prevent the suspension and delisting of its stock until the hearing concludes. However, there is no guarantee that the appeal will be successful and that the company's stock will continue to be listed on the Nasdaq Capital Market.
根据Benzinga Pro提供的数据，ALLR的52周最高价为269.80美元，52周最低价为0.32美元。
According to data from Benzinga Pro, ALLR has a 52-week high of $269.80 and a 52-week low of $0.32.
根据Benzinga Pro的数据，ALLR的52周最高价为$269.80，52周最低价为$0.32。